Cita APA

Tohmé, R., Izadmehr, S., Gandhe, S., Tabaro, G., Vallabhaneni, S., Thomas, A., . . . Narla, G. (2019). Direct activation of PP2A for the treatment of tyrosine kinase inhibitor–resistant lung adenocarcinoma. JCI Insight.

Chicago Style Citation

Tohmé, Rita, et al. "Direct Activation of PP2A for the Treatment of Tyrosine Kinase Inhibitor–resistant Lung Adenocarcinoma." JCI Insight 2019.

Cita MLA

Tohmé, Rita, et al. "Direct Activation of PP2A for the Treatment of Tyrosine Kinase Inhibitor–resistant Lung Adenocarcinoma." JCI Insight 2019.